ASX
Alterity Therapeutics Limited
ATH:ASX•Healthcare
Sensitive ASX Announcement
EU Regulatory Guidance for ATH434 Phase 2 Clinical Trial
Published: 23/06/21, 10:56am (AEST)•2 pages